Statins Decrease the Risk of Orbitopathy in Newly Diagnosed Patients with Graves Disease

Teprotumumab for the Treatment of Active Thyroid Eye Disease

(2020) Raymond S. Douglas et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy: A New Starting Point for the Therapy

(2020) Giulia Lanzolla et al.   Frontiers in Endocrinology

Putative protective role of autoantibodies against the insulin-like growth factor-1 receptor in Graves’ Disease: results of a pilot study

(2020) G. Lanzolla et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Simvastatin downregulates adipogenesis in 3T3-L1 preadipocytes and orbital fibroblasts from Graves’ ophthalmopathy patients

(2019) B Shahida et al.   Endocrine Connections

Tobacco Product Use and Cessation Indicators Among Adults — United States, 2018

(2019) MeLisa R. Creamer et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

The anti-inflammatory effects of statins on patients with rheumatoid arthritis: A systemic review and meta-analysis of 15 randomized controlled trials

(2018) Guo-min Li et al.   AUTOIMMUNITY REVIEWS

High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional Study

(2018) Elena Sabini et al.   THYROID

Relationship between serum cholesterol and Graves’ orbitopathy (GO): a confirmatory study

(2018) G. Lanzolla et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial

(2018) George J Kahaly et al.   Lancet Diabetes & Endocrinology

Insulin-like growth factor-I receptor and thyroid-associated ophthalmopathy

(2018) Terry J Smith et al.   ENDOCRINE REVIEWS

Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves’ disease and Graves’ orbitopathy

(2018) M. Marinò et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Teprotumumab for Thyroid-Associated Ophthalmopathy

(2017) Terry J. Smith et al.   NEW ENGLAND JOURNAL OF MEDICINE

Current Insights into the Pathogenesis of Graves’ Ophthalmopathy

(2015) R. Bahn   HORMONE AND METABOLIC RESEARCH

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials

(2015)   LANCET

Risk Factors for Developing Thyroid-Associated Ophthalmopathy Among Individuals With Graves Disease

(2015) Joshua D. Stein et al.   JAMA Ophthalmology

Management plan and delivery of care in Graves’ ophthalmopathy patients

(2012) Morgan Yang et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Rheumatoid arthritis

(2011) Loreto Carmona et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Statin use in patients with asthma - a nationwide population-based study

(2010) Chin-Chou Huang et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Anti-inflammatory effects of simvastatin on adipokines in type 2 diabetic patients with carotid atherosclerosis

(2009) Yun Hu et al.   Diabetes & Vascular Disease Research

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Statins as emerging treatments for asthma and chronic obstructive pulmonary disease

(2008) Garry M Walsh   Expert Review of Respiratory Medicine